621 related articles for article (PubMed ID: 27327800)
1. Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease.
Ganz P; Heidecker B; Hveem K; Jonasson C; Kato S; Segal MR; Sterling DG; Williams SA
JAMA; 2016 Jun; 315(23):2532-41. PubMed ID: 27327800
[TBL] [Abstract][Full Text] [Related]
2. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
Pursnani A; Massaro JM; D'Agostino RB; O'Donnell CJ; Hoffmann U
JAMA; 2015 Jul; 314(2):134-41. PubMed ID: 26172893
[TBL] [Abstract][Full Text] [Related]
3. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.
Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; May M; Brindle P
BMJ; 2007 Jul; 335(7611):136. PubMed ID: 17615182
[TBL] [Abstract][Full Text] [Related]
4. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.
Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; Minhas R; Sheikh A; Brindle P
BMJ; 2008 Jun; 336(7659):1475-82. PubMed ID: 18573856
[TBL] [Abstract][Full Text] [Related]
5. Traditional Risk Factors Versus Biomarkers for Prediction of Secondary Events in Patients With Stable Coronary Heart Disease: From the Heart and Soul Study.
Beatty AL; Ku IA; Bibbins-Domingo K; Christenson RH; DeFilippi CR; Ganz P; Ix JH; Lloyd-Jones D; Omland T; Sabatine MS; Schiller NB; Shlipak MG; Skali H; Takeuchi M; Vittinghoff E; Whooley MA
J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26150476
[TBL] [Abstract][Full Text] [Related]
6. Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study.
Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; Brindle P
Heart; 2008 Jan; 94(1):34-9. PubMed ID: 17916661
[TBL] [Abstract][Full Text] [Related]
7. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study.
Liu J; Hong Y; D'Agostino RB; Wu Z; Wang W; Sun J; Wilson PW; Kannel WB; Zhao D
JAMA; 2004 Jun; 291(21):2591-9. PubMed ID: 15173150
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of High-Sensitivity Cardiac Troponin T Compared with Risk Scores in Stable Cardiovascular Disease.
Biener M; Giannitsis E; Kuhner M; Zelniker T; Mueller-Hennessen M; Vafaie M; Trenk D; Neumann FJ; Hochholzer W; Katus HA
Am J Med; 2017 May; 130(5):572-582. PubMed ID: 28011313
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.
Ridker PM; Buring JE; Rifai N; Cook NR
JAMA; 2007 Feb; 297(6):611-9. PubMed ID: 17299196
[TBL] [Abstract][Full Text] [Related]
11. Derivation and validation of a set of 10-year cardiovascular risk predictive functions in Spain: the FRESCO Study.
Marrugat J; Subirana I; Ramos R; Vila J; Marín-Ibañez A; Guembe MJ; Rigo F; Tormo Díaz MJ; Moreno-Iribas C; Cabré JJ; Segura A; Baena-Díez JM; de la Cámara AG; Lapetra J; Grau M; Quesada M; Medrano MJ; González Diego P; Frontera G; Gavrila D; Aicua EA; Basora J; García JM; García-Lareo M; Gutierrez JA; Mayoral E; Sala J; D'Agostino R; Elosua R;
Prev Med; 2014 Apr; 61():66-74. PubMed ID: 24412897
[TBL] [Abstract][Full Text] [Related]
12. Association of Multiorgan Computed Tomographic Phenomap With Adverse Cardiovascular Health Outcomes: The Framingham Heart Study.
Shah RV; Yeri AS; Murthy VL; Massaro JM; D'Agostino R; Freedman JE; Long MT; Fox CS; Das S; Benjamin EJ; Vasan RS; O'Donnell CJ; Hoffmann U
JAMA Cardiol; 2017 Nov; 2(11):1236-1246. PubMed ID: 28975197
[TBL] [Abstract][Full Text] [Related]
13. Assessing and Refining Myocardial Infarction Risk Estimation Among Patients With Human Immunodeficiency Virus: A Study by the Centers for AIDS Research Network of Integrated Clinical Systems.
Feinstein MJ; Nance RM; Drozd DR; Ning H; Delaney JA; Heckbert SR; Budoff MJ; Mathews WC; Kitahata MM; Saag MS; Eron JJ; Moore RD; Achenbach CJ; Lloyd-Jones DM; Crane HM
JAMA Cardiol; 2017 Feb; 2(2):155-162. PubMed ID: 28002550
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 3 Predictive Clinical Risk Scores in 603 Patients with Stable Coronary Artery Disease.
Aceña Á; Martín-Mariscal ML; Tarín N; Cristóbal C; Huelmos A; Pello A; Carda R; Alonso J; Lorenzo Ó; Mahíllo-Fernández I; Tuñón J
Tex Heart Inst J; 2017 Aug; 44(4):239-244. PubMed ID: 28878576
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Large-Scale Proteomics for Prediction of Cardiovascular Events.
Helgason H; Eiriksdottir T; Ulfarsson MO; Choudhary A; Lund SH; Ivarsdottir EV; Hjorleifsson Eldjarn G; Einarsson G; Ferkingstad E; Moore KHS; Honarpour N; Liu T; Wang H; Hucko T; Sabatine MS; Morrow DA; Giugliano RP; Ostrowski SR; Pedersen OB; Bundgaard H; Erikstrup C; Arnar DO; Thorgeirsson G; Masson G; Magnusson OT; Saemundsdottir J; Gretarsdottir S; Steinthorsdottir V; Thorleifsson G; Helgadottir A; Sulem P; Thorsteinsdottir U; Holm H; Gudbjartsson D; Stefansson K
JAMA; 2023 Aug; 330(8):725-735. PubMed ID: 37606673
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
[TBL] [Abstract][Full Text] [Related]
17. Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease.
Ngo D; Sinha S; Shen D; Kuhn EW; Keyes MJ; Shi X; Benson MD; O'Sullivan JF; Keshishian H; Farrell LA; Fifer MA; Vasan RS; Sabatine MS; Larson MG; Carr SA; Wang TJ; Gerszten RE
Circulation; 2016 Jul; 134(4):270-85. PubMed ID: 27444932
[TBL] [Abstract][Full Text] [Related]
18. Performance of Framingham cardiovascular disease (CVD) predictions in the Rotterdam Study taking into account competing risks and disentangling CVD into coronary heart disease (CHD) and stroke.
van Kempen BJ; Ferket BS; Kavousi M; Leening MJ; Steyerberg EW; Ikram MA; Witteman JC; Hofman A; Franco OH; Hunink MG
Int J Cardiol; 2014 Feb; 171(3):413-8. PubMed ID: 24438922
[TBL] [Abstract][Full Text] [Related]
19. A modified Essen stroke risk score for predicting recurrent cardiovascular events: development and validation.
Sumi S; Origasa H; Houkin K; Terayama Y; Uchiyama S; Daida H; Shigematsu H; Goto S; Tanaka K; Miyamoto S; Minematsu K; Matsumoto M; Okada Y; Sato M; Suzuki N
Int J Stroke; 2013 Jun; 8(4):251-7. PubMed ID: 22759563
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study.
Kavousi M; Elias-Smale S; Rutten JH; Leening MJ; Vliegenthart R; Verwoert GC; Krestin GP; Oudkerk M; de Maat MP; Leebeek FW; Mattace-Raso FU; Lindemans J; Hofman A; Steyerberg EW; van der Lugt A; van den Meiracker AH; Witteman JC
Ann Intern Med; 2012 Mar; 156(6):438-44. PubMed ID: 22431676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
